Drug
Luvesilocin clinical trials
Keep track of what changes. Save the luvesilocin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
- RE104 for Injection
- 4
Studies by the year they started
4 studies that test it; most in 2024 (2)
| Year | Studies |
|---|---|
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Reunion Neuroscience Inc (4)
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses luvesilocin is read from its arms, and is right about nine times in ten.
Testing it · 4
- RE104 Safety and Efficacy Study in Generalized Anxiety DisorderRecruitingPhase 2Reunion Neuroscience IncNCT07489651Written as RE104 for Injection
- RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical IllnessesRecruitingPhase 2Reunion Neuroscience IncNCT07002034Written as RE104 for Injection
- RE104 Safety and Efficacy Study in Postpartum DepressionCompletedPhase 2Reunion Neuroscience IncNCT06342310Written as RE104 for Injection
- RE104 Clinical Lactation StudyCompletedPhase 1Reunion Neuroscience IncNCT06659263Written as RE104 for Injection
Codes
What other systems call luvesilocin · ClinicalTrials.gg INT016917
- UNII (FDA) J64JU3Z4Q2LUVESILOCINConfirmed FDA, Wikidata
- Wikidata Q118896392luvesilocinConfirmed FDA, Wikidata
- NCI Thesaurus C217735LuvesilocinOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | J64JU3Z4Q2 | LUVESILOCIN | Confirmed FDA, Wikidata |
| Wikidata | Q118896392 | luvesilocin | Confirmed FDA, Wikidata |
| NCI Thesaurus | C217735 | Luvesilocin | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.